Literature DB >> 15641474

[Obesity and non-alcoholic steatohepatitis].

Nahum Méndez-Sánchez1, Norberto C Chávez-Tapia, Misael Uribe.   

Abstract

Obesity is the most important risk factor associated with non-alcoholic steatohepatitis, which is caused by to impaired insulin activity, overflow of portal triglycerides, and production of inflammatory cytokines; all of these are deleterious to hepatocytes. These phenomena facilitate disruptions in hepatic physiology, as observed in alcoholic hepatitis; however, consumption of this substance is absent. Non-alcoholic steatohepatitis has had a great impact due to the fact that previously, main cases of cryptogenic cirrhosis actually were attributed to this disease. Despite advances in understanding the pathophysiologic process of the disease, there is no better treatment than weight reduction (a combination of diet and exercise). In this issue, we describe the most important topics with regard to non-alcoholic steatohepatitis and the obesity-related process.

Entities:  

Mesh:

Year:  2004        PMID: 15641474

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  3 in total

1.  Smoking is not associated with nonalcoholic fatty liver disease.

Authors:  Norberto-C Chavez-Tapia; Javier Lizardi-Cervera; Oliver Perez-Bautista; Martha H Ramos-Ostos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

2.  Association among C-reactive protein, Fatty liver disease, and cardiovascular risk.

Authors:  Javier Lizardi-Cervera; Norberto C Chavez-Tapia; Oliver Pérez-Bautista; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

3.  Nuclear receptors in nonalcoholic Fatty liver disease.

Authors:  Jorge A López-Velázquez; Luis D Carrillo-Córdova; Norberto C Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez
Journal:  J Lipids       Date:  2011-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.